Barrow, Hanley, Mewhinney & Strauss’s Elanco Animal Health ELAN Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3K	Sell	623 -3,581,778	-100%	-$82.8M	﹤0.01%	206
2026 Q1	$85.7M	Sell	3,582,401 -730,685	-17%	-$17.9M	0.28%	89
2025 Q4	$97.6M	Sell	4,313,086 -723,061	-14%	-$15.7M	0.33%	81
2025 Q3	$101M	Sell	5,036,147 -2,592,747	-34%	-$43.4M	0.32%	76
2025 Q2	$109M	Buy	7,628,894 +64,623	+0.9%	+$755K	0.37%	73
2025 Q1	$79.4M	Buy	+7,564,271	New	+$85.6M	0.29%	78

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's ELAN Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss reduced its Elanco Animal Health (ELAN) stake by 100% in Q2 2026, selling an estimated $82.8M and leaving 623 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ELAN in Q1 2025 and has held it in 6 quarters since. The position peaked at $109M in Q2 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Barrow, Hanley, Mewhinney & Strauss held 623 shares of Elanco Animal Health worth $15.3K as of Q2 2026.
Barrow, Hanley, Mewhinney & Strauss sold 3,581,778 Elanco Animal Health shares in Q2 2026, an estimated $82.8M.
Elanco Animal Health made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #206 holding.
Barrow, Hanley, Mewhinney & Strauss first reported a position in Elanco Animal Health in Q1 2025 and has held it in 6 quarters since.
Barrow, Hanley, Mewhinney & Strauss's Elanco Animal Health position peaked at $109M in Q2 2025.
520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.